Lab Corp (LH) Extends Tender for Orchid Cellmark (ORCH)

Laboratory Corporation (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on December 9, 2011, LabCorp’s previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (Nasdaq: ORCH). On May 17, 2011, LabCorp received a request from the Federal Trade Commission, or the FTC, for additional information under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the acquisition of Orchid by LabCorp. LabCorp previously extended its tender offer to November 30, 2011. LabCorp is continuing to cooperate with the FTC’s request for additional information and is consequently further extending the expiration of the tender offer.

The depositary for the tender offer has advised LabCorp that as of 5:00 p.m., New York City time on November 30, 2011, stockholders of Orchid had validly tendered, and not withdrawn, 26,463,575 shares of Orchid common stock, including 56,631 shares of Orchid common stock tendered through notices of guaranteed delivery. The shares tendered represent approximately 88.2% of the outstanding shares of Orchid, and approximately 88.0% excluding the shares tendered by notices of guaranteed delivery (or approximately 80.9% and 80.7%, respectively, calculated on a fully diluted basis).

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Paramount Global (PARA) and Skydance are closer to a merger - CNBC
• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Methanex (MEOH) Appoints Roger Perreault to its Board